8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE CAS#: 691868-88-9

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE

生物活性靶点体外研究体内研究用途与合成方法 MSDS 8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE价格(试剂级) 上下游产品信息

中文名称	8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
中文同义词	8-(1,3,4-噁二唑-2-基)-2,4-双(三氟甲基)咪唑并[1,2-Α][1,8]萘啶;2-(2,4-二(三氟甲基)咪唑并[1,2-A][1,8]萘啶-8-基)-1,3,4-恶二唑;化合物RO8191;IFN-α Receptor 2 Agonist, RO8191 - Calbiochem[5092250001]
英文名称	8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE
英文同义词	8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE;RO8191;Imidazo[1,2-a][1,8]naphthyridine, 8-(1,3,4-oxadiazol-2-yl)-2,4-bis(trifluoromethyl)-;2-[2,4-Bis(trifluoromethyl)imidazo[1,2-a]1,8-naphthyridin-8-yl]-1,3,4-oxadiazole;CDM-3008;RO4948191;HCV,Inhibitor,JAK,Hepatitis C virus,Interferon-alpha/beta receptor,CDM3008,Janus kinase,EMCV,CDM 3008,Tyk2,RO-4948191,RO 4948191,HBV,RO8191,interferon,orally,IFNAR,ISGs,cccDNA,IFNAR1,STAT,inhibit,JAK1,RO-8191,RO 8191,Hepatitis B virus,IFNAR2,imidazonaphthyridine,Interferon-α/β receptor,replicon;IFN-α Receptor 2 Agonist, RO8191 - Calbiochem[5092250001]
CAS号	691868-88-9
分子式	C14H5F6N5O
分子量	373.21
EINECS号
相关类别
Mol文件	Mol File
结构式

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE 性质

储存条件	Store at 2-8°C
溶解度	DMSO 中≤0.1mg/ml；二甲基甲酰胺中≤0.5mg/ml
形态	结晶固体
颜色	米白色至黄色
InChIKey	GRHYZVJEXKTJOS-UHFFFAOYSA-N
SMILES	FC(F)(F)c1nc2[n]3c(nc(c3)c4nnc[o]4)ccc2c(c1)C(F)(F)F

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE 用途与合成方法

生物活性

RO8191 (CDM-3008) 是一种咪唑啉并吡啶化合物，是具有口服活性的，有效的干扰素 (IFN) 受体激动剂。RO8191 直接与 IFNα/β 受体 2 (IFNAR2) 结合，激活 IFN 刺激的基因 (ISGs) 表达和 JAK/STAT 磷酸化。RO8191 对 HCV 和 EMCV 均显示抗病毒活性，对 HCV 复制子的 IC50 为 200 nM。RO8191 通过具有干扰素样活性发挥 cccDNA 调节剂 (CDM) 作用，并具有抗 HBV 活性。

靶点

JAK1

IFNAR2

体外研究

RO8191 (CDM-3008) exerts antiviral activity dependent on IFNAR2/JAK1, but is independent of IFNAR1/Tyk2. RO8191, an IFNAR2 agonist, stimulates IFN signals in mice.
RO8191 (0.08, 0.4, 2, 10 μM; for 72 h) strongly suppresses HCV replicon activity at 72 h in a dose-dependent manner. RO8191 reduces levels of the proteins HCV NS3 and NS4A, which are localized mainly in the perinuclear region of the replicon cells.
RO8191 (0.08-10 μM; for 72 h) results in the disappearance of viral proteins such as NS3, NS4A/B, and NS5A/B.

体内研究

RO8191 (CDM-3008; 30 mg/kg; oral) significantly induces antiviral genes Oas1b, Mx1, and Pkr in the livers of six-week-old C57BL/6J mice.

安全信息

WGK Germany	WGK 3
存储类别	11 - 可燃固体

MSDS信息

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE 价格(试剂级)

更新日期	产品编号	产品名称	CAS号	包装	价格
2025/12/22	HY-W063968	RO8191	691868-88-9	1 mg	500元
2025/12/22	HY-W063968	8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE RO8191	691868-88-9	5mg	1100元

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE